Nanoliposomes that were decorated with a thyroid-stimulating hormone (TSH) were prepared in order to target specifically the TSH receptor (TSHr), which is a glycoprotein expressed in the plasma membranes of thyrocytes, and is maintained in most thyroid pathologies and also present in the majority of less differentiated and more aggressive tumors [143]. The gene discussed is TSHR; the disease is thyroid gland disorder.